This study presents the characterization of MI uptake in rat intestine as evaluated using purified membrane preparations. Three secondary active myo-inositol (MI) cotransporters have been identified; two are Na + -coupled (SMIT1 and SMIT2) and one is H + -coupled (HMIT). Through inhibition studies using selective substrates such as Dchiro-inositol (DCI, specific for SMIT2) and L-fucose (specific for SMIT1), we show that SMIT2 is exclusively responsible for apical MI transport in rat intestine; rabbit intestine appears to lack apical transport of MI. Other sugar transport systems known to be present in apical membranes, such as SGLT1 or GLUT5, lacked any significant contribution to MI uptake. Functional analysis of rat SMIT2 activity, via electrophysiological studies in Xenopus oocytes, demonstrated similarities to the activities of SMIT2 from species (rabbit and human), displaying high affinities for MI (0.150 ± 0.040 mM), DCI (0.31 ± 0.06 mM) and Pz (0.016 ± 0.007 mM), low affinity for glucose (36 ± 7 mM) and no affinity for L-fucose. While these functional characteristics essentially confirmed those found in rat intestinal apical membranes, a unique discrepancy was seen between the two systems studied in that the affinity for glucose was about 40-fold higher in vesicles (K i = 0.94 ± 0.35 mM) than in oocytes. Finally, the transport system responsible for the basolateral efflux of glucose in intestine, GLUT2, did not mediate any significant radiolabelled MI uptake in oocytes, indicating that this transport system does not participate in the basolateral exit of MI from small intestine.
INTRODUCTION
The physiological importance of myo-inositol (MI) is generally considered to reflect its role in signal transduction as a precursor to phosphoinositides and inositol phosphates. In addition, MI acts as a "compatible osmolyte" in specific tissues, such as brain and kidney medulla, where variations in milieu osmolarity may threaten normal cell function. In response to an increase in osmolarity, intracellular MI concentration may rise up to 500 fold above its plasma concentration of approximately 30 µM (9, 11) , where it prevents the accumulation effects of high ionic concentrations, which leads to DNA degradation (Dmitrieva and Burg, 2005) (12) . This has been well documented in brain where conditions such as trauma (30) , oedema and hypernatremia (26, 27, 38) have been shown to increase MI levels. In order to reach such high intracellular concentrations, secondary active transport systems are required for MI.
Three such MI cotransport systems have been identified, two of which are sodium-dependent (SMIT1 and SMIT2) while the third is proton-dependent (HMIT) (36). SMIT1, the first MI transport system identified, is primarily expressed in brain and renal medulla (22) . In the kidney (where MI transport has been most extensively studied), the protein is located at the basolateral membranes of epithelial cells (2, 39) and its activity is tightly regulated by osmotic variations through a tonicity-responsive system (16, 20) .
This regulation is most important in renal medulla where the interstitial osmolarity fluctuates drastically according to hydration status.
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More recently, our laboratory has identified a second sodium-dependent transporter SMIT2 (10) . Like SMIT1, SMIT2 is expressed in the brain, intestine and kidney and, although both systems share remarkable functional similarities (high affinities for MI, overall substrate and inhibitor specificities and 2:1 Na + /MI stoichiometry), some differences distinguish the two transport systems: unlike SMIT1, which is highly expressed in the kidney medulla, SMIT2 is predominantly found in kidney cortex where it is expressed at the apical domains of proximal tubule cells (2, 23) .
With this cellular location, SMIT2 is believed to be responsible for the reabsorption of MI from the glomerular filtrate, a conclusion which has been supported by MI uptake studies performed both on purified rabbit kidney brush border membrane vesicles (BBMv) (23) and on a stably SMIT2-transfected cell line (MDCK-SMIT2) (2) . As well, there is no evidence that SMIT2 is regulated by osmolarity conditions, which is in accordance with its cortical location in kidney. A significant difference between the two SMIT transport systems concerns D-chiro-inositol (DCI), a MI epimer which is transported by SMIT2 with high affinity but is not transported by SMIT1 (10) . In contrast, L-fucose is transported by SMIT1 but not by SMIT2. For these reasons, DCI and L-fucose can be used to functionally discriminate the two systems in tissues where they coexist (2) .
A study performed on purified rat BBMv prior to the molecular identification of SMIT1 suggested the existence of a sodium-dependent MI transport system (34) . In agreement with this conclusion, the dietary requirement for MI was first established using gerbils, linking an MI-free diet to pathological conditions such as lipodistrophy of the small intestine, presumably due to failure in lipid absorption through chylomicrons (7, Page 4 of 37 18) , and dysregulation of triglyceride metabolism in the liver (19) . Using purified BBMv, we now demonstrate through extensive characterization that, in the rat, SMIT2 is present in the apical membranes of enterocytes and is responsible for all MI absorption. This is in contrast to a recently published hypothesis that SMIT2 may play a significant role in glucose uptake in intestine (37) . 
MATERIALS AND METHODS

Materials
Isolation of purified brush border membranes:
Brush border membranes from rat and rabbit intestinal mucosal scrapings were purified as described earlier for rabbit kidney (2) . The membranes were prepared in batches using 6 to 10 rats (or 2 to 3 rabbits) and used fresh or kept frozen in liquid nitrogen until use (stored less than four weeks). The composition of the intravesicular medium consisted of (in mM) 200 KCl, 0.1 MgSO 4 , 300 mannitol and 50 Hepes-Tris pH 7. (21) and inserted into the vector pT7TS which had previously been cleaved with Bgl II and Spe I. After cloning, the recombinant vector was purified and then cleaved with EcoR I; mRNA was transcribed using the T7 mMessage mMachine kit from Ambion (Austin, TX).
Oocyte preparation, injection of cRNA and incubation:
Procedures for oocytes isolated from Xenopus laevis were as previously described (2) . On the day following isolation, oocytes were injected with either 46 ng human GLUT2 mRNA (46 nl at 1 µg/µl) (13) for 2DG uptake assays or 4.6 ng rat SMIT2 mRNA (46 nl at 0.1 µg/µl) for electrophysiology studies and incubated in Barth's solution supplemented with 5% horse serum. 2.5 mM Na pyruvate and antibiotics (penicillin, streptomycin and kanamycin) for 5 to 7 days prior to assay.
Electrophysiology:
Oocyte currents were measured with a two microelectrode voltage clamp technique as previously described (4 
Transport studies:
A) On BBMv: Uptake of radiolabelled MI was performed as described elsewhere using a standard filtration technique (23 (1) . Filters were then dissolved in 5 ml scintillation cocktail (Betablend, ICN Biochemicals Inc., CA) and radioactivity was monitored using a Beckman LS6000 SC scintillation counter. B) On oocytes: uptakes were performed as already described (2). Control or GLUT2-injected oocytes were tested for both 2DG
and MI uptake. Oocytes were incubated in Barth's solution containing tracer amount of substrate (1µl/ml 3 H-MI or 3 H-2DG) with or without saturating cold substrate (10 mM MI or 2DG) to separate specific and non-specific uptake.
qRT-PCR:
Quantification of both SMIT1 and SMIT2 mRNA was performed using LUX technology employing a SuperScript TM III Platinum® one-step qRT-PCR System kit (Invitrogen). Total RNA was isolated from kidney cortices and intestinal mucosa from rats and rabbits using the Trizol® extraction procedure. Both rabbit and rat SMIT2 mRNA as well as dog SMIT1 mRNA were used as standards for quantification of specific mRNAs using procedures described elsewhere (23) .
Data analysis:
Determination of kinetic parameters was performed using Origin 6.1 software 
RESULTS
Myo-inositol transport in intestinal BBMv:
Past studies of transporters using BBMv purified from both intestine and kidney were often performed using rabbits as they provide large quantities of material and a high degree of purification. In a previous paper from our laboratory, BBMv purified from rabbit kidney were successfully used to characterize the luminal transport of MI (23) . A similar set of experiments was thus performed to investigate MI uptake processes in the rabbit intestine. Figure 1A depicts uptake-time curves for MI in BBMv in either the presence ( ) or absence ( ) of saturating amounts of cold substrate (10 mM). To our surprise, all experiments using rabbit intestine (8 assays) failed to show typical uptake curves comprising overshoot and rapid settling back to equilibrium level, although two assays did present a twofold increase of tracer MI uptake over that seen under saturating conditions. On the other hand, BBMv purified from rat small intestine ( Figure 1B) showed high levels of specific MI uptake. As shown, a typical overshoot indicative of secondary active transport systems is found under tracer conditions while simple equilibration is achieved if 10 mM cold MI is present in the uptake media. The overshoot was observed for the first minute of uptake and the amount of intravesicular, radiolabelled MI attained over 4 times the equilibrium level which was reached within 10 min. Such a clear distinction between the MI uptake seen with rabbit and rat led us to quantify the presence of both SMIT transporters in kidney and intestine for both rat and rabbit. As shown in Figure 2 , quantification of SMIT2 mRNA through qRT-PCR shows equivalent expression levels in rat for both kidney and intestine while in rabbit only the kidney expresses SMIT2 mRNA with barely any SMIT2 detection in intestine.
Characterization of MI transport in purified rat BBMv:
As rabbit intestine lacked any specific MI uptakes, we used rat BBMv in order to clearly identify the nature of the transporter (s) involved and to define the kinetics of MI transport activities. Descriptive characterization of MI transport was achieved by performing initial MI uptakes (15 seconds) in the presence of known substrates and/or inhibitors of the two SMIT subtypes. This complete characterization is presented in Figure 3 . Initial uptakes of radiolabelled MI (0.16 pmol/mg protein x 15 seconds) were challenged by different concentrations of the following agents: cold MI and glucose (up to 2 mM), DCI and Pz (up to 1 mM). The initial uptake (Ctrl) was also performed in the absence of sodium (K + replacement) in order to identify any possible Na + -independent pathway for MI in BBMv. In addition, MI uptake was tested with the glucose facilitated transport inhibitor phloretin (Pt, 1 mM), L-Fucose (100 mM), the GLUT-specific substrate 2-deoxyglucose (2DG, 10 mM) and with the SGLT1-specific substrate alpha-methylglucose (AMG, 10 mM).
As expected, all MI accumulation within the BBMv was completely Na + -dependent as uptake in the absence of sodium was similar to that found in the presence of excess cold MI. Furthermore, since increasing amounts of DCI completely inhibited specific MI uptake while 100 mM L-fucose failed to reduce uptake significantly, it can be concluded that there is no evidence for any SMIT1 activity in rat BBMv while SMIT2
(the DCI-sensitive transporter) appeared to be responsible for all MI transport observed.
As expected from the properties of rabbit SMIT2 (28), 5 µM Pz was efficient in inhibiting MI uptake while Pt was without effect. Furthermore, the SGLT1 and GLUT transport systems showed no evidence of being involved in BBMv MI transport since high concentrations of their specific substrates (AMG and 2DG, respectively) failed to alter initial uptake of 0.36 nM MI. It is interesting that 1 mM D-glucose is effective in reducing the level of MI transport while 10 mM AMG fails to inhibit MI transport significantly. This is consistent with the reported properties of rabbit SMIT2 where 50 mM AMG did not stimulate a cotransport current but 50 mM D-glucose did (10). We thus conclude that, in rat intestine, SMIT2 is the only transport system involved in the apical uptake of MI.
In the next set of experiments, inhibition curves were used to evaluate kinetic parameters using an analysis technique based on the competitive inhibition of tracer uptake by either its own substrate or by true competitive inhibitors (28) . Km and V max values were thus first determined for MI, and were then set as constant parameters for the evaluation of K i values for all other effectors (DCI, glucose and Pz). Figure 3 were used to determine affinities for DCI, glucose and Pz. As experiments were performed under the same conditions as those for MI, the kinetic constants previously determined for MI in Figure 4 were used as constants here. As seen, DCI exhibits a K i value (146 ± 9 µM) similar to that of MI while the glucose K m is sixfold higher (0.9 ± 0.35 mM). On the other hand, Pz is a potent inhibitor with a K i of 15 ± 6 µM.
Characterization of rat SMIT2 expressed in Xenopus oocytes:
Rat SMIT2 was expressed in Xenopus oocytes in order to assess kinetic parameters for substrates (MI, DCI and glucose) and an inhibitor (Pz) specifically for the rat SMIT2 protein, as determined in a heterologous system, and compare them to values obtained from rat intestinal BBMv. Figure 5A depicts current-voltage curves generated by plotting the oocyte current caused by the addition of MI (0 to 1 mM) at different membrane potentials. The currents elicited by MI at a given membrane potential were then plotted against the corresponding MI concentrations in order to determine the affinity for this substrate ( Figure 5B ). The same approach was used to determine the affinities for the two other substrates: DCI (up to 1 mM) and glucose (up to 50 mM).
Similarly, the K i value for Pz was determined by fitting the currents induced by 0.1mM MI in the presence of different Pz concentrations. For this purpose, the kinetic values (K m and I max ) determined for MI (see Figure 5B ) were used as constants in a competitive inhibition equation in order to properly evaluate the K i value of Pz. The K m values remained fairly constant at different membrane potentials (see Figure 5C ). All kinetic parameters determined on oocytes are presented in Table 1 along with those already determined in BBMv. The kinetic parameters evaluated in oocytes showed similar affinities for MI (280 ± 19 µM), DCI (310 ± 56 µM) and Pz (16 ± 7 µM) to those measured in BBMv whereas the glucose affinity in oocytes is remarkably low (35.5 ± 7.3 mM), about forty times lower than that seen with BBMv.
Comparing glucose and MI transport in purified rat BBMv:
In order to compare the activity levels of SMIT2 and SGLT1 in rat BBMv, tracer MI uptakes were compared to tracer glucose uptakes using the same vesicle preparations. Figure 6 presents initial uptakes (up to 10 sec) for both MI ( ) and glucose ( ) set at 0.4 nM along with linear regression analysis performed on the data in order to evaluate initial uptake capacities. As seen in this figure, tracer glucose uptake (0.0185 pmol / min) is six-fold higher that that found with MI (0.0033 pmol / min). Very similar ratios were found within all assays performed (n = 5). Given the low substrate concentrations used, the affinities of the two transporters for their substrates are unimportant and the data represents the true relative amounts of transport activity.
GLUT2 as a basolateral exit pathway for MI:
As nutrients absorbed by enterocytes usually leave the cell through specific
basolateral transport systems, we tested the possibility that GLUT2, the only basolateral pathway for glucose, could mediate the exit of MI. The human GLUT2 transporter was thus expressed in X. laevis oocytes and tested for the specific uptake of radiolabelled MI.
As seen in Figure 7 , GLUT2 is unable to mediate MI transport, as barely any specific accumulation of MI is observed. On the other hand, 2DG, a specific substrate for GLUT2, was transported with great efficacy, as shown by the 67-fold increase in uptake of radiolabelled substrate in GLUT2-injected oocytes over that for control oocytes.
DISCUSSION
In a previous report (24), we presented a complete characterization of MI transport in purified BBMv isolated from rabbit kidney where we concluded that SMIT2
is responsible for the reuptake of MI from the kidney ultrafiltrate. Extending this study to intestinal tissue was a logical step as both tissues share obvious functional similarities.
Initial studies performed on rabbit intestinal BBMv did not, however, show any evidence for the existence of an MI transport system, as shown in Figure 1A . This difference between rabbit and rat can tentatively be explained by the fact that almost all of the rabbit dietary MI is found as phytate, a hexakisphosphate derivative of MI which essentially functions as a metal ligand in plants (17, 18) . In contrast, free MI is by far the major form of inositol found in the rat diet (19) . It was thus not surprising to find MI transport in BBMv isolated from rat, as seen in Figure 1B , and no corresponding uptake in rabbit vesicles ( Figure 1A ). However, a study showing the existence of a Na + -dependent MI transport system in an herbivorous fish indicates that herbivores do not always lack Na + /MI cotransport (35) . Figure 1B demonstrates a classical overshoot of MI uptake that rapidly subsides within a few minutes, indicative of secondary active MI uptake. A similar assay performed in the presence of saturating MI ( ) only showed equilibration of the substrate. This data is very similar to that already observed with BBMv purified from rabbit kidney (24) . This species difference for SMIT2 expression in intestine is corroborated by qRT-PCR data ( Figure 2 ) indicating that SMIT2 transcripts are essentially absent from rabbit enterocytes and are not simply located in other cellular compartments (as is seen with GLUT4 which is located within intracellular stores when not needed) (31). In fact, the existence of a Na + -dependent MI transport system in the rat intestine had already been demonstrated in purified BBMv (34) , although without extensive characterization of the transport system(s) involved. We further pursued this investigation in rat BBMv in order to better characterize this activity in regards to its molecular identity and transport properties.
Characterization of MI transport performed through inhibition assays (Figure 3) enabled us to identify the transport protein involved in this process. Using DCI and Lfucose as discriminating substrates for the two SMITs, we showed that only SMIT2
mediates MI transport in rat intestinal BBMv (Figure 3 ), as DCI completely inhibited transport while 100 mM L-fucose failed to significantly alter MI uptake. Although complete inhibition of mediated MI transport by DCI is sufficient to identify SMIT2 as the unique transport system in this tissue, two other sugar transport systems which are present in the BBMv were also considered. First, the possible involvement of the fructose-specific transporter GLUT5 in MI transport was refuted since 2DG, a specific substrate for GLUTs including rat GLUT5 (32), did not alter the uptake of tracer MI even at 10 mM ( Figure 3, lower panel) . Also, as all MI transport was Na + -dependent, as seen by the complete dissipation of mediated uptake when Na + is replaced by isosmolar K + (0 Na + ), any involvement of GLUT proteins or by HMIT could be excluded since they all are Na + -independent. The second system considered, the Na + -glucose transporter SGLT1, was also ruled out since 10 mM AMG failed to significantly inhibit tracer MI uptake. The use of 10 mM AMG as a specific condition for evaluating the possible contribution of SGLT1 to MI uptake was justified by the fact that this concentration is much higher than the K m of this specific substrate for SGLT1 (0.4 mM, (25)) yet it does not appear to affect cloned rabbit SMIT2 (10) . In addition, rat SMIT2 has even less affinity for AMG than does the rabbit protein since AMG superfusion could not elicit any current in oocytes expressing rat SMIT2, even at 50 mM (R. Aouameur, unpublished observation). Finally, as expected for a Na + -dependent sugar transport system, SMIT2 shows great affinity towards Pz (15 ± 6 µM). The K m value found for MI with rat BBMv (150 ± 40 µM) is comparable to that found by Scalera et al on a similar preparation (34) or to that found using rabbit kidney BBMv (15, 24) .
When comparing the various kinetic parameters described for SMIT2 between the oocyte expression system and BBMv, the single noteworthy difference concerns the affinity for glucose. Although the glucose affinity found for rat SMIT2 expressed in oocytes (mean K m value of 4 assays = 35.5 ± 7.3 mM) is compatible with the affinities previously reported for rabbit SMIT2 (10), the K i values found in BBMv assays are remarkably lower (mean value of 4 assays = 0.90 ± 0.35 mM). A possible role for SGLT1 activity in affecting measurements of glucose inhibition of SMIT2, such as rapid dissipation of sodium gradient or reduced membrane potential, is unlikely since a high concentration of AMG (10 mM) did not significantly alter tracer uptake of MI. Also, as seen in Figure 5C , the K m for SMIT2 is not influenced by more positive membrane potentials, indicating that a change in membrane potential should not reduce MI uptake.
We cannot rule out the possibility that SGLT1 is involved in the unusually low K i value for glucose inhibition of SMIT2 but any actual mechanism must be more complex than simple competitive inhibition. To sum up the comparisons, although MI and DCI compete the transport of radiolabelled MI with K i values that are consistent with their measured K m in oocytes and Pz inhibits radiolabelled MI uptake in BBMv with a K i value that is also observed in electrophysiological experiments, the observed K m value for D-glucose-induced current is 40 times larger than the K i observed in BBMvs. This indicates that the mechanism used for inhibition is different from the mechanism used for transport. The difference maybe that in oocyte SMIT2 is alone but in BBMv, the activity of SMIT2 is measured in the presence of an intense transport activity mediated by SGLT1. Inhibition of SMIT2 must involve a site separate from that required for cotransport, which may be inside or outside the membrane, and will require future study.
Our data appear to be in agreement with the study from Scalera et al. (34) evaluating MI uptake in rat BBMv, where glucose was shown to be an inhibitor with mixed-type mechanism and with very weak transport efficiency.
Many reports have stressed the dietary need for MI. Studies in gerbils have linked intestinal MI uptake to lipid metabolism and chylomicron synthesis as its removal from the diet was shown to generate pathological conditions such as intestinal lipodystrophy and liver dysfunction of lipid metabolism (5-8, 18, 19) . As MI metabolism seems to occur within enterocytes (19) , the existence of a basolateral pathway for its exit may not be required as it is for other absorbed nutrients such as glucose although there is evidence of ingested MI appearing in both mouse and human plasma (3, 14) . There is in fish, however, a single report presenting data for a basolateral pathway for MI (33) and, as expected, this transport is diffusive (Na + -independent). In mammals, on the other hand, GLUT2 is the basolateral pathway responsible for the exit of glucose from enterocytes and proximal convoluted tubule (kidney) cells. Consequently, we examined the possibility that this sugar transporter could mediate MI transport but no specific uptake was observed when this transporter was expressed in oocytes ( Figure 7 ). Assays using purified basolateral membranes to identify a specific pathway for MI exit are presently underway in our lab.
Comparing the uptake of glucose and MI into BBMv shows that SGLT1 activity is about 6x stronger than SMIT2 activity ( Figure 6 ). When considering that the K m value for intestinal glucose transport on SGLT1 (140 µM, (29)) is very similar to that for MI determined on SMIT2 (150 µM, herein), it can be concluded that SGLT1 glucose transport activity should be 6x larger that of SMIT2 in the rat intestine for equimolar concentrations of glucose and MI. With its very weak affinity for glucose, a significant participation of SMIT2 in intestinal glucose uptake seems unlikely. This is corroborated by the glucose-galactose malabsorption (GGM) syndrome in humans, characterized by a deficit in SGLT1 function, which is not obviously compensated for by the presence of SMIT2. Evaluation of competition between the two substrates for SMIT2 transport is largely meaningless in the absence of fixed luminal glucose and MI concentrations. In kidney, where both transporters are also found and glucose and MI concentrations are stable, such consideration becomes relevant but will depend on the specific intranephronic location of MI and glucose cotransporters (24) .
In conclusion, we have presented evidence for SMIT2-dependent uptake of MI in the apical domain of rat enterocytes similar to those already determined in rabbit kidney (24) . Evaluation of uptake into BBMv were performed as previously described (28) while oocytes currents were analyzed using classical equations (MichaelisMenten and competitive inhibition). Values presented are mean ± SEM. 
